Adaptation of high-growth influenza H5N1 vaccine virus in Vero cells: implications for pandemic preparedness (Q30224923)

5 September 2017

Adaptation of high-growth influenza H5N1 vaccine virus in Vero cells: implications for pandemic preparedness (English)

1 reference

5 September 2017

0 references

0 references

pandemic preparedness

1 reference

Yu-Fen Tseng

1

1 reference

5 September 2017

Alan Yung-Chih Hu

2

1 reference

5 September 2017

Mei-Liang Huang

3

1 reference

5 September 2017

Wei-Zhou Yeh

4

1 reference

5 September 2017

Tsai-Chuan Weng

5

1 reference

5 September 2017

Yu-Shuan Chen

6

1 reference

5 September 2017

Pele Chong

7

1 reference

5 September 2017

Min-Shi Lee

8

1 reference

5 September 2017

language of work or name

English

0 references

publication date

13 October 2011

1 reference

5 September 2017

1 reference

5 September 2017

6

1 reference

5 September 2017

10

1 reference

5 September 2017

e24057

1 reference

Creative Commons Attribution 4.0 International

5 September 2017

start time

13 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Emergence and pandemic potential of swine-origin H1N1 influenza virus

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Progress with human H5N1 vaccines: a perspective from industry.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Enhanced growth of seed viruses for H5N1 influenza vaccines

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

H5N1 vaccines: how prepared are we for a pandemic?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

The role of cell culture vaccines in the control of the next influenza pandemic.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Future influenza vaccines and the use of genetic recombinants

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Laboratory and clinical characteristics of attenuated strains of influenza virus

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines, March 2007

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192705

10.1371/JOURNAL.PONE.0024057

26 November 2018

Identifiers

DOI

1 reference

5 September 2017

0 references

1 reference

5 September 2017

PubMed publication ID

22022351

1 reference